资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医讯达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
map
#HIV疫苗#
35篇内容 | 1954人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=c22089214a, topicName=HIV疫苗, introduction=HIV疫苗, content=null, image=null, comments=35, allHits=1954, url=https://h5.medsci.cn/topic?id=8921, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=21466, tagList=[TagDto(tagId=21466, tagName=HIV疫苗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1479705, encodeId=833a14e9705b6, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=新冠疫苗研发速度如此之快,为什么HIV疫苗就这么难?, objectType=article, longId=728169, objectId=ec75e2816927, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec75e2816927, replyNumber=0, likeNumber=94, createdTime=2022-05-31, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec75e2816927, moduleTitle=新冠疫苗研发速度如此之快,为什么HIV疫苗就这么难?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ec75e2816927)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479704, encodeId=f3f714e9704a5, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=强生HIV疫苗重大试验失败,HIV疫苗研发依然面临挑战, objectType=article, longId=217093, objectId=ab8f21e09342, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab8f21e09342, replyNumber=0, likeNumber=95, createdTime=2021-09-16, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab8f21e09342, moduleTitle=强生HIV疫苗重大试验失败,HIV疫苗研发依然面临挑战, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ab8f21e09342)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479703, encodeId=132c14e9703aa, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Moderna将启动基于mRNA技术的HIV疫苗临床试验, objectType=article, longId=215997, objectId=526421599e08, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=526421599e08, replyNumber=0, likeNumber=81, createdTime=2021-08-21, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=526421599e08, moduleTitle=Moderna将启动基于mRNA技术的HIV疫苗临床试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=526421599e08)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479702, encodeId=541814e97025d, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=NEJM:ALVAC-HIV疫苗的中期有效性如何?, objectType=article, longId=209112, objectId=af2120911262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af2120911262, replyNumber=0, likeNumber=76, createdTime=2021-03-29, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af2120911262, moduleTitle=NEJM:ALVAC-HIV疫苗的中期有效性如何?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=af2120911262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479701, encodeId=70af14e9701b7, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=NEJM:ALVAC-HIV疫苗接种方案在南非2b-3期临床研究失败, objectType=article, longId=209012, objectId=404d20901249, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=404d20901249, replyNumber=0, likeNumber=106, createdTime=2021-03-27, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=404d20901249, moduleTitle=NEJM:ALVAC-HIV疫苗接种方案在南非2b-3期临床研究失败, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=404d20901249)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479700, encodeId=b2ff14e970054, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=mSphere:HIV疫苗接种对HIV感染后抗体反应的影响, objectType=article, longId=201683, objectId=cba420168335, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cba420168335, replyNumber=0, likeNumber=89, createdTime=2020-10-06, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cba420168335, moduleTitle=mSphere:HIV疫苗接种对HIV感染后抗体反应的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cba420168335)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479699, encodeId=22de14e96998a, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Immunity:实验性HIV疫苗的里程碑!, objectType=article, longId=183556, objectId=7412183556ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7412183556ad, replyNumber=0, likeNumber=103, createdTime=2019-11-26, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7412183556ad, moduleTitle=Immunity:实验性HIV疫苗的里程碑!, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7412183556ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479698, encodeId=575b14e96984f, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Science:如何产生引发广泛中和抗体反应的通用HIV疫苗?, objectType=article, longId=182422, objectId=f48718242220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f48718242220, replyNumber=0, likeNumber=100, createdTime=2019-11-07, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f48718242220, moduleTitle=Science:如何产生引发广泛中和抗体反应的通用HIV疫苗?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f48718242220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479697, encodeId=264e14e96975c, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=SCI TRANS MED:病毒性HIV疫苗可持久保护免受致死病毒的伤害, objectType=article, longId=176461, objectId=cbc81e646199, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbc81e646199, replyNumber=0, likeNumber=82, createdTime=2019-07-31, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbc81e646199, moduleTitle=SCI TRANS MED:病毒性HIV疫苗可持久保护免受致死病毒的伤害, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cbc81e646199)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479696, encodeId=fb2614e96964b, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=研究性四价HIV疫苗:正在一步步实现, objectType=article, longId=175432, objectId=5b6d1e5432af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b6d1e5432af, replyNumber=0, likeNumber=72, createdTime=2019-07-16, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b6d1e5432af, moduleTitle=研究性四价HIV疫苗:正在一步步实现, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5b6d1e5432af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479695, encodeId=25fa14e9695e3, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Lancet HIV :重组腺病毒PG9-HIV疫苗的安全性研究, objectType=article, longId=162661, objectId=ceb016266114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceb016266114, replyNumber=0, likeNumber=105, createdTime=2019-03-22, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceb016266114, moduleTitle=Lancet HIV :重组腺病毒PG9-HIV疫苗的安全性研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ceb016266114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479694, encodeId=991014e9694b0, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Sci Transl Med:HIV疫苗研究的曙光, objectType=article, longId=142852, objectId=34e4142852ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34e4142852ee, replyNumber=0, likeNumber=87, createdTime=2018-07-11, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34e4142852ee, moduleTitle=Sci Transl Med:HIV疫苗研究的曙光, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=34e4142852ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479693, encodeId=305714e969329, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Sci Transl Med:震惊!双盲研究显示HIV疫苗在病毒抑制中无效,HIV攻克之路异常艰难, objectType=article, longId=122788, objectId=409c122e885b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=409c122e885b, replyNumber=0, likeNumber=77, createdTime=2017-12-10, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=409c122e885b, moduleTitle=Sci Transl Med:震惊!双盲研究显示HIV疫苗在病毒抑制中无效,HIV攻克之路异常艰难, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=409c122e885b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479692, encodeId=10cf14e969208, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Immunity:一种新抗体的出现使HIV疫苗研发大步前进!, objectType=article, longId=121070, objectId=126e1210e0bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=126e1210e0bb, replyNumber=0, likeNumber=82, createdTime=2017-11-24, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=126e1210e0bb, moduleTitle=Immunity:一种新抗体的出现使HIV疫苗研发大步前进!, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=126e1210e0bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479691, encodeId=352814e96910a, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=重磅!科学家破解HIV疫苗开发困境!, objectType=article, longId=113602, objectId=a4d3113602c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4d3113602c9, replyNumber=0, likeNumber=91, createdTime=2017-09-23, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4d3113602c9, moduleTitle=重磅!科学家破解HIV疫苗开发困境!, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a4d3113602c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479690, encodeId=dd0e14e9690dc, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Nat Commun:新的HIV疫苗方案, objectType=article, longId=101352, objectId=7b7610135248, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b7610135248, replyNumber=0, likeNumber=100, createdTime=2017-06-11, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b7610135248, moduleTitle=Nat Commun:新的HIV疫苗方案, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7b7610135248)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479689, encodeId=cd3b14e968935, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=临床实验结果显示,Inovio公司HIV疫苗免疫响应率接近100%, objectType=article, longId=101052, objectId=67b410105255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67b410105255, replyNumber=0, likeNumber=75, createdTime=2017-06-02, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67b410105255, moduleTitle=临床实验结果显示,Inovio公司HIV疫苗免疫响应率接近100%, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=67b410105255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479688, encodeId=969b14e9688de, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Cell Chem Bio:突破—HIV疫苗将会提前问世,从根本上解决艾滋病问题, objectType=article, longId=99854, objectId=af71998541d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af71998541d, replyNumber=0, likeNumber=92, createdTime=2017-05-28, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af71998541d, moduleTitle=Cell Chem Bio:突破—HIV疫苗将会提前问世,从根本上解决艾滋病问题, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=af71998541d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479687, encodeId=321314e968757, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=多篇文章夯实基础 HIV疫苗成功开发指日可待!, objectType=article, longId=93792, objectId=7eda93e9256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7eda93e9256, replyNumber=0, likeNumber=87, createdTime=2017-03-27, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7eda93e9256, moduleTitle=多篇文章夯实基础 HIV疫苗成功开发指日可待!, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7eda93e9256)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479686, encodeId=58e714e96862a, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=HIV疫苗将在近几年问世,从源头解决感染问题, objectType=article, longId=88736, objectId=c49488e3633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c49488e3633, replyNumber=0, likeNumber=117, createdTime=2017-02-15, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c49488e3633, moduleTitle=HIV疫苗将在近几年问世,从源头解决感染问题, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c49488e3633)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
HIV疫苗
2020-05-29
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
新冠疫苗研发速度如此之快,为什么HIV疫苗就这么难?
94
0
2022-05-31
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
强生HIV疫苗重大试验失败,HIV疫苗研发依然面临挑战
95
0
2021-09-16
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
Moderna将启动基于mRNA技术的HIV疫苗临床试验
81
0
2021-08-21
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
NEJM:ALVAC-HIV疫苗的中期有效性如何?
76
0
2021-03-29
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
NEJM:ALVAC-HIV疫苗接种方案在南非2b-3期临床研究失败
106
0
2021-03-27
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
mSphere:HIV疫苗接种对HIV感染后抗体反应的影响
89
0
2020-10-06
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
Immunity:实验性HIV疫苗的里程碑!
103
0
2019-11-26
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
Science:如何产生引发广泛中和抗体反应的通用HIV疫苗?
100
0
2019-11-07
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
SCI TRANS MED:病毒性HIV疫苗可持久保护免受致死病毒的伤害
82
0
2019-07-31
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
研究性四价HIV疫苗:正在一步步实现
72
0
2019-07-16
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
Lancet HIV :重组腺病毒PG9-HIV疫苗的安全性研究
105
0
2019-03-22
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
Sci Transl Med:HIV疫苗研究的曙光
87
0
2018-07-11
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
Sci Transl Med:震惊!双盲研究显示HIV疫苗在病毒抑制中无效,HIV攻克之路异常艰难
77
0
2017-12-10
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
Immunity:一种新抗体的出现使HIV疫苗研发大步前进!
82
0
2017-11-24
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
重磅!科学家破解HIV疫苗开发困境!
91
0
2017-09-23
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
Nat Commun:新的HIV疫苗方案
100
0
2017-06-11
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
临床实验结果显示,Inovio公司HIV疫苗免疫响应率接近100%
75
0
2017-06-02
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
Cell Chem Bio:突破—HIV疫苗将会提前问世,从根本上解决艾滋病问题
92
0
2017-05-28
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
多篇文章夯实基础 HIV疫苗成功开发指日可待!
87
0
2017-03-27
回复
ms306040998833292
(审核中...)
关注
已关注
前往app查看评论内容
#HIV疫苗#
HIV疫苗将在近几年问世,从源头解决感染问题
117
0
2017-02-15
回复
共35条
首页
上一页
下一页
尾页
页码:
1
/2页
20条/页
扫描二维码下载梅斯医学APP
map
科室
订阅+
更多科室
工具
服务
map
map